Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICUCW) Revenue (2023 - 2025)

SeaStar Medical Holding's Revenue history spans 3 years, with the latest figure at $386000.0 for Q4 2025.

  • For Q4 2025, Revenue rose 476.12% year-over-year to $386000.0; the TTM value through Dec 2025 reached $1.2 million, up 788.89%, while the annual FY2025 figure was $1.2 million, 788.89% up from the prior year.
  • Revenue reached $386000.0 in Q4 2025 per ICUCW's latest filing, up from $183000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $386000.0 in Q4 2025 to a low of -$433000.0 in Q1 2023.
  • Average Revenue over 3 years is $84625.0, with a median of $125500.0 recorded in 2024.
  • The largest YoY upside for Revenue was 476.12% in 2025 against a maximum downside of 169.12% in 2025.
  • A 3-year view of Revenue shows it stood at -$225000.0 in 2023, then surged by 129.78% to $67000.0 in 2024, then soared by 476.12% to $386000.0 in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Revenue are $386000.0 (Q4 2025), $183000.0 (Q3 2025), and $338000.0 (Q2 2025).